bioAffinity Technologies, Inc. (BIAF) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts BIAF Hot Sheet
Join SI Premium – FREE
bioAffinity Technologies, Inc. (NASDAQ: BIAF) reported Q2 EPS of ($0.17), $0.07 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on bioAffinity Technologies, Inc. (BIAF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
- Bernstein SocGen Group Reiterates Outperform Rating on Boeing (BA)
- monday.com Ltd. (MNDY) Tops Q2 EPS by 37c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
